Immunotherapy of Advanced Bladder Cancer – Daniel Petrylak – UroToday
UroTodayImmunotherapy of Advanced Bladder Cancer – Daniel PetrylakUroTodayDaniel Petrylak, MD presents response rates and anti-tumor activity of checkpoint inhibition therapy in patients with advanced urothelial carcinoma and immunotherapy as initial t… Continue reading
